Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle
Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engin...
Gespeichert in:
Veröffentlicht in: | Tissue engineering. Part A 2011-07, Vol.17 (13-14), p.1747-1758 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1758 |
---|---|
container_issue | 13-14 |
container_start_page | 1747 |
container_title | Tissue engineering. Part A |
container_volume | 17 |
creator | Koning, Merel Werker, Paul M.N. van Luyn, Marja J.A. Harmsen, Martin C. |
description | Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC).
In vivo
, SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC
in vivo
, SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC
in vitro
. During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of
NCAM
. The gene expression of the myogenic transcription factors
PAX7
,
MYF5
, and
MYOD
was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins
MYL1
and
MYL3
was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis
in vitro
, at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool. |
doi_str_mv | 10.1089/ten.tea.2010.0624 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_883030563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A274871180</galeid><sourcerecordid>A274871180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</originalsourceid><addsrcrecordid>eNqNkkFrHCEUx6W0NMm2H6CXIs2hp93qqKPb23ZJu4WEBpJCb-LMPBfTGd2qA9ljv3kcNgmkFFpFnzx-_z8-fQi9oWRBiVp-yOAXGcyiIiVD6oo_Q8d0yeScMfHj-eOZ0yN0ktINITWppXyJjirKmaprcYx-b_a7cOsMvoxhCBnSdOidhWiyCx4HizfjYDy-2IcteNfiK5Oh710GvC4xfcQrfFmEPjvT40_gwZo2h4idx9cupRHwmd86DxCd305-Vz-hh1zgizG1PbxCL6zpE7y-jzP0_fPZ9XozP__25et6dT5vhWJ5DpZLJqolU6KjhgimpLBlt4TXrCOqEi21qulIQ6qmUYpXpOIN4aAay6mSbIbeH3x3MfwaIWU9uNSWEoyHMCatFCOMiJr9m5RMErEsghl69wd5E8boSxkTxGQZvECnB2hretDO25CjaSdLvaokV5JSRQq1-AtVZgeDa0N5VlfyTwT0IGhjSCmC1bvoBhP3mhI9tYcun1KW0VN76Kk9iubt_X3HZoDuUfHQDwWQB2BKG-97Bw3E_B_Wd_p7yBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>873377774</pqid></control><display><type>article</type><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</creator><creatorcontrib>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</creatorcontrib><description>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC).
In vivo
, SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC
in vivo
, SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC
in vitro
. During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of
NCAM
. The gene expression of the myogenic transcription factors
PAX7
,
MYF5
, and
MYOD
was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins
MYL1
and
MYL3
was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis
in vitro
, at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</description><identifier>ISSN: 1937-3341</identifier><identifier>EISSN: 1937-335X</identifier><identifier>DOI: 10.1089/ten.tea.2010.0624</identifier><identifier>PMID: 21438665</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adult ; Aged ; Biomarkers - metabolism ; Cell Differentiation - drug effects ; Cell Hypoxia - drug effects ; Cell proliferation ; Cell Proliferation - drug effects ; Cell Shape - drug effects ; Cells ; Cells, Cultured ; Desmin - metabolism ; Female ; Fibroblasts - cytology ; Fibroblasts - drug effects ; Gene Expression Regulation - drug effects ; Humans ; Hypoxia ; Male ; Middle Aged ; Models, Biological ; Muscle, Skeletal - cytology ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - physiology ; Muscles ; Muscular system ; Neural Cell Adhesion Molecules - metabolism ; Original Articles ; Oxygen - pharmacology ; PAX7 Transcription Factor - metabolism ; Physiological aspects ; Satellite Cells, Skeletal Muscle - cytology ; Satellite Cells, Skeletal Muscle - drug effects ; Satellite Cells, Skeletal Muscle - metabolism ; Skeletal system ; Tissue engineering ; Tissue Engineering - methods</subject><ispartof>Tissue engineering. Part A, 2011-07, Vol.17 (13-14), p.1747-1758</ispartof><rights>2011, Mary Ann Liebert, Inc.</rights><rights>COPYRIGHT 2011 Mary Ann Liebert, Inc.</rights><rights>(©) Copyright 2011, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</citedby><cites>FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21438665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koning, Merel</creatorcontrib><creatorcontrib>Werker, Paul M.N.</creatorcontrib><creatorcontrib>van Luyn, Marja J.A.</creatorcontrib><creatorcontrib>Harmsen, Martin C.</creatorcontrib><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><title>Tissue engineering. Part A</title><addtitle>Tissue Eng Part A</addtitle><description>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC).
In vivo
, SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC
in vivo
, SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC
in vitro
. During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of
NCAM
. The gene expression of the myogenic transcription factors
PAX7
,
MYF5
, and
MYOD
was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins
MYL1
and
MYL3
was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis
in vitro
, at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Hypoxia - drug effects</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Shape - drug effects</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Desmin - metabolism</subject><subject>Female</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - drug effects</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Muscle, Skeletal - cytology</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - physiology</subject><subject>Muscles</subject><subject>Muscular system</subject><subject>Neural Cell Adhesion Molecules - metabolism</subject><subject>Original Articles</subject><subject>Oxygen - pharmacology</subject><subject>PAX7 Transcription Factor - metabolism</subject><subject>Physiological aspects</subject><subject>Satellite Cells, Skeletal Muscle - cytology</subject><subject>Satellite Cells, Skeletal Muscle - drug effects</subject><subject>Satellite Cells, Skeletal Muscle - metabolism</subject><subject>Skeletal system</subject><subject>Tissue engineering</subject><subject>Tissue Engineering - methods</subject><issn>1937-3341</issn><issn>1937-335X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkkFrHCEUx6W0NMm2H6CXIs2hp93qqKPb23ZJu4WEBpJCb-LMPBfTGd2qA9ljv3kcNgmkFFpFnzx-_z8-fQi9oWRBiVp-yOAXGcyiIiVD6oo_Q8d0yeScMfHj-eOZ0yN0ktINITWppXyJjirKmaprcYx-b_a7cOsMvoxhCBnSdOidhWiyCx4HizfjYDy-2IcteNfiK5Oh710GvC4xfcQrfFmEPjvT40_gwZo2h4idx9cupRHwmd86DxCd305-Vz-hh1zgizG1PbxCL6zpE7y-jzP0_fPZ9XozP__25et6dT5vhWJ5DpZLJqolU6KjhgimpLBlt4TXrCOqEi21qulIQ6qmUYpXpOIN4aAay6mSbIbeH3x3MfwaIWU9uNSWEoyHMCatFCOMiJr9m5RMErEsghl69wd5E8boSxkTxGQZvECnB2hretDO25CjaSdLvaokV5JSRQq1-AtVZgeDa0N5VlfyTwT0IGhjSCmC1bvoBhP3mhI9tYcun1KW0VN76Kk9iubt_X3HZoDuUfHQDwWQB2BKG-97Bw3E_B_Wd_p7yBI</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Koning, Merel</creator><creator>Werker, Paul M.N.</creator><creator>van Luyn, Marja J.A.</creator><creator>Harmsen, Martin C.</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110701</creationdate><title>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</title><author>Koning, Merel ; Werker, Paul M.N. ; van Luyn, Marja J.A. ; Harmsen, Martin C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-ef473529385d1a053875f538f0463d0825c1f8bd0b02bb8842024b04e8bf41873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Hypoxia - drug effects</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Shape - drug effects</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Desmin - metabolism</topic><topic>Female</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - drug effects</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Muscle, Skeletal - cytology</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - physiology</topic><topic>Muscles</topic><topic>Muscular system</topic><topic>Neural Cell Adhesion Molecules - metabolism</topic><topic>Original Articles</topic><topic>Oxygen - pharmacology</topic><topic>PAX7 Transcription Factor - metabolism</topic><topic>Physiological aspects</topic><topic>Satellite Cells, Skeletal Muscle - cytology</topic><topic>Satellite Cells, Skeletal Muscle - drug effects</topic><topic>Satellite Cells, Skeletal Muscle - metabolism</topic><topic>Skeletal system</topic><topic>Tissue engineering</topic><topic>Tissue Engineering - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koning, Merel</creatorcontrib><creatorcontrib>Werker, Paul M.N.</creatorcontrib><creatorcontrib>van Luyn, Marja J.A.</creatorcontrib><creatorcontrib>Harmsen, Martin C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Tissue engineering. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koning, Merel</au><au>Werker, Paul M.N.</au><au>van Luyn, Marja J.A.</au><au>Harmsen, Martin C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle</atitle><jtitle>Tissue engineering. Part A</jtitle><addtitle>Tissue Eng Part A</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>17</volume><issue>13-14</issue><spage>1747</spage><epage>1758</epage><pages>1747-1758</pages><issn>1937-3341</issn><eissn>1937-335X</eissn><abstract>Facial paralysis is a physically, psychologically, and socially disabling condition. Innovative treatment strategies based on regenerative medicine, in particular tissue engineering of skeletal muscle, are promising for treatment of patients with facial paralysis. The natural source for tissue-engineered muscle would be muscle stem cells, that is, human satellite cells (SC).
In vivo
, SC respond to hypoxic, ischemic muscle damage by activation, proliferation, differentiation to myotubes, and maturation to muscle fibers, while maintaining their reserve pool of SC. Therefore, our hypothesis is that hypoxia improves proliferation and differentiation of SC. During tissue engineering, a three-dimensional construct, or implanting SC
in vivo
, SC will encounter hypoxic environments. Thus, we set out to test our hypothesis on SC
in vitro
. During the first five passages, hypoxically cultured SC proliferated faster than their counterparts under normoxia. Moreover, also at higher passages, a switch from normoxia to hypoxia enhanced proliferation of SC. Hypoxia did not affect the expression of SC markers desmin and NCAM. However, the average surface expression per cell of NCAM was downregulated by hypoxia, and it also downregulated the gene expression of
NCAM
. The gene expression of the myogenic transcription factors
PAX7
,
MYF5
, and
MYOD
was upregulated by hypoxia. Moreover, gene expression of structural proteins α-sarcomeric actin, and myosins
MYL1
and
MYL3
was upregulated by hypoxia during differentiation. This indicates that hypoxia promotes a promyogenic shift in SC. Finally, Pax7 expression was not influenced by hypoxia and maintained in a subset of mononucleated cells, whereas these cells were devoid of structural muscle proteins. This suggests that during myogenesis
in vitro
, at least part of the SC adopt a quiescent, that is, reserve cells, phenotype. In conclusion, tissue engineering under hypoxic conditions would seem favorable in terms of myogenic proliferation, while maintaining the quiescent SC pool.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>21438665</pmid><doi>10.1089/ten.tea.2010.0624</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1937-3341 |
ispartof | Tissue engineering. Part A, 2011-07, Vol.17 (13-14), p.1747-1758 |
issn | 1937-3341 1937-335X |
language | eng |
recordid | cdi_proquest_miscellaneous_883030563 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Biomarkers - metabolism Cell Differentiation - drug effects Cell Hypoxia - drug effects Cell proliferation Cell Proliferation - drug effects Cell Shape - drug effects Cells Cells, Cultured Desmin - metabolism Female Fibroblasts - cytology Fibroblasts - drug effects Gene Expression Regulation - drug effects Humans Hypoxia Male Middle Aged Models, Biological Muscle, Skeletal - cytology Muscle, Skeletal - drug effects Muscle, Skeletal - physiology Muscles Muscular system Neural Cell Adhesion Molecules - metabolism Original Articles Oxygen - pharmacology PAX7 Transcription Factor - metabolism Physiological aspects Satellite Cells, Skeletal Muscle - cytology Satellite Cells, Skeletal Muscle - drug effects Satellite Cells, Skeletal Muscle - metabolism Skeletal system Tissue engineering Tissue Engineering - methods |
title | Hypoxia Promotes Proliferation of Human Myogenic Satellite Cells: A Potential Benefactor in Tissue Engineering of Skeletal Muscle |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T00%3A05%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoxia%20Promotes%20Proliferation%20of%20Human%20Myogenic%20Satellite%20Cells:%20A%20Potential%20Benefactor%20in%20Tissue%20Engineering%20of%20Skeletal%20Muscle&rft.jtitle=Tissue%20engineering.%20Part%20A&rft.au=Koning,%20Merel&rft.date=2011-07-01&rft.volume=17&rft.issue=13-14&rft.spage=1747&rft.epage=1758&rft.pages=1747-1758&rft.issn=1937-3341&rft.eissn=1937-335X&rft_id=info:doi/10.1089/ten.tea.2010.0624&rft_dat=%3Cgale_proqu%3EA274871180%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=873377774&rft_id=info:pmid/21438665&rft_galeid=A274871180&rfr_iscdi=true |